Allogeneic stem cell transplantation is a potentially curative therapy for patients with acute myeloid leukemia (AML) after achieving complete remission (CR). The aim of this study is to evaluate the optimal dose of thiotepa, administered as part of the thiotepa-busulfan-fludarabine (TBF) conditioning regimen for allogeneic stem cell transplantation in adults with AML in CR.
Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party
La Nasa, Giorgio;
2020-01-01
Abstract
Allogeneic stem cell transplantation is a potentially curative therapy for patients with acute myeloid leukemia (AML) after achieving complete remission (CR). The aim of this study is to evaluate the optimal dose of thiotepa, administered as part of the thiotepa-busulfan-fludarabine (TBF) conditioning regimen for allogeneic stem cell transplantation in adults with AML in CR.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Effect of the Thiotepa Dose in the TBFConditioning Regimen in Patients UndergoingAllogeneic Stem Cell Transplantation for AcuteMyeloid Leukemia in Complete Remission.pdf
Solo gestori archivio
Tipologia:
versione post-print
Dimensione
514.92 kB
Formato
Adobe PDF
|
514.92 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
